He promoted ESI in NSL, then NSL in ESI and ACW in NEU all within hours. Those are just the ones I noticed. Seems a bit dodge that you're allowed to write 3/4 about one stock then spend the last quarter talking about another stock to try and get people interested.
Each to their own I guess.
FDA Grants Orphan Drug Designation, page-26
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.85 |
Change
-0.320(1.59%) |
Mkt cap ! $2.543B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.74 | $2.758M | 138.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 256 | $19.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.85 | 25 | 3 |
View Market Depth
| Last trade - 15.27pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |